Polypodium Leucotomos Extract.
Research-backed herb with potential health benefits. Helps your skin resist UV damage from the sun. Think of it as a base layer of protection you take as a pill. Also shows promise for some inflammatory skin conditions.
Reviewed March 2026
- Category
- Herb
What Polypodium Leucotomos Extract is, and what it does.
- Does it work
- It's an interesting niche supplement. If you're very fair, have a history of sun damage, or have specific skin issues like melasma, it's worth a look. For everyone else, probably not necessary.
- How much to take
- 240 mg to 480 mg daily. Take it in the morning, especially 30 minutes before you plan to be in the sun.
- Time to feel it
- Trials dose it a few hours before light exposure and read skin response the same day. The steadier effect across a sunny week builds over two to four weeks of daily use.
- The first dose
- Nothing. This isn't a drug. It needs to build up in your system over a couple of weeks.
- With regular use
- After a month, you'll likely notice your skin is more resilient to sun. You might get tan instead of just burning, or the redness fades faster. The benefits are preventative.
- How well tolerated
- Considered well tolerated in studies. No major side effects reported beyond occasional stomach issues. But it is not, and will never be, a substitute for actual sunscreen.
- How it feels
- Like nothing. It works behind the scenes. The only 'feeling' is the retrospective one of 'huh, I didn't get as sunburned as I usually do'.
- The overlooked benefit
- It travels in the blood, so it reaches skin you forgot to cover, like ear tops and a scalp parting. It forms no film and blocks no light, so sunscreen still does that job.
120 to 240mg a day is where Polypodium Leucotomos Extract works.
Source: Nestor et al., 2015; Middelkamp-Hup et al., 2004
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Polypodium Leucotomos Extract is documented in the library; the clinical read is in the queue. Nothing about the strength of the research prints until the read is done.
- skin redness response after ultraviolet exposureRandomised trial
- even skin tone through a sunny seasonRandomised trial
- antioxidant enzyme signalling in skin cellsIn vitro study
- markers of oxidative stress after light exposureRandomised trial
Questions people ask about Polypodium Leucotomos Extract.
- So I can skip sunscreen?
- Absolutely not. This is a sidekick, not the hero. Think of it as 10% extra help. Sunscreen is the other 90%.
- How long does it take to work?
- Give it at least 2-4 weeks of daily use to see a difference in your skin's resilience.
- Is it safe to take every day?
- Yes, studies have shown it's well tolerated in long-term daily use.
- Any specific brand I should look for?
- Look for products using a standardized extract like Fernblock®. It’s the one used in most of the research.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Polypodium phenolics quench reactive species generated in skin after light exposure, and ascorbate regenerates the phenolic pool as it is spent. Ascorbate is separately the cofactor for the hydroxylases that build new dermal collagen.
Tocopherol protects membrane lipids from peroxidation, the compartment where light-driven radical chains propagate. Water-soluble phenolics from the fern regenerate it at the membrane interface, so the two spare each other.
Nicotinamide replenishes cellular NAD, which keeps DNA repair enzymes and ATP production running in keratinocytes after light exposure. That is an energy and repair mechanism, separate from radical quenching.
Astaxanthin sits across the lipid bilayer and is an efficient singlet oxygen quencher, the species light generates most in skin. Polyphenolics from the fern act in the aqueous phase instead.
Carotenoids accumulate in skin over weeks and quench singlet oxygen there. Combining a slow-loading carotenoid with a fern extract taken acutely before exposure covers two different time courses.
Both are polyphenol-rich extracts used orally for skin resilience, acting through radical quenching and effects on matrix breakdown. Stacking them adds polyphenol dose more than it adds a distinct mechanism.
Green tea catechins and fern phenolics both quench light-driven reactive species in skin and both are cleared through glucuronidation. Their mechanisms and their clearance route overlap substantially.
Lutein accumulates in skin after oral intake and absorbs light toward the blue end of the visible spectrum. A phenolic fern extract works on the radical chemistry that follows light absorption rather than on the light itself. Placing the two at different points in the sequence is the basis of the pairing.
Zeaxanthin deposits in skin alongside lutein and shares its light-absorbing range. It contributes a filtering component that a water-soluble phenolic extract cannot provide. The pairing rests on complementary physical chemistry rather than on a combination trial.
Lycopene is among the most efficient quenchers of singlet oxygen, a species generated in skin by ultraviolet and visible light. Phenolic acids are better at intercepting hydrogen-abstracting radicals. Different reactive species, different chemistry, which is why formulas carry both.
Collagen peptides supply amino acids and small di- and tripeptides relevant to dermal matrix turnover. The fern extract addresses the oxidative side of skin stress. Combining them covers structure and oxidative load separately, and no shared mechanism is being claimed.
Ubiquinol interrupts lipid peroxidation chains inside membranes, a compartment aqueous phenolics reach poorly. The extract's phenolic acids operate in the water phase. Covering both physical environments is the reason the two appear together.
Glutathione is the dominant intracellular thiol buffer in skin cells and is drawn down when reactive species accumulate. Extract phenolics intercept radicals in the extracellular and membrane-adjacent space. The compartments differ, which is the substance of the pairing.
N-acetylcysteine supplies the cysteine that limits glutathione synthesis, supporting the intracellular thiol pool. That pool is what handles peroxides enzymatically. This is settled pathway biochemistry and not a tested combination with the extract.
Dihydrolipoic acid works in both aqueous and lipid environments and can return other antioxidants to their reduced state. A phenolic radical is in principle recyclable rather than simply consumed. The mechanism is redox chemistry; no joint clinical data underlies it.
Glutathione peroxidase and thioredoxin reductase both carry a selenocysteine residue, so selenium status sets the ceiling on enzymatic peroxide handling in skin. Plant phenolics scavenge non-enzymatically. Selenium is a precondition for one arm of the defence rather than a second antioxidant of the same kind.
Sulforaphane is a well-characterised inducer of NRF2 signalling, raising expression of the cell's own antioxidant and phase II enzymes over hours to days. Direct radical scavenging by a phenolic extract acts immediately. The two operate on different timescales, which is the reason to run them together.
Vitamin D is made in skin only when UVB reaches the epidermis, so anything that changes sun behaviour changes that input. People using oral photoprotection are often limiting deliberate sun exposure at the same time. The interaction is behavioural and biochemical rather than chemical between the two molecules.
EPA and DHA are incorporated into skin cell membranes and change the substrate pool available to cyclooxygenase and lipoxygenase. That is a compositional effect independent of radical scavenging. The two lines of action do not overlap, which is why they are combined.
Tocotrienols sit within membranes and stop lipid peroxidation chains, with a distribution that differs from tocopherol because of the unsaturated tail. Aqueous phenolics do not reach that compartment. The combination covers two physical environments.
Hyaluronic acid relates to dermal water binding rather than to radical chemistry. Its presence alongside the extract covers a different aspect of normal skin structure. The pairing is a formulation choice with no shared mechanism.
Ceramides are structural lipids of the skin barrier and are used orally with barrier-integrity intent. The extract addresses oxidative load. Nothing chemical passes between them, and the combination is compositional.
Resveratrol and the extract's cinnamic acid derivatives are both phenolics that donate hydrogen to radicals and influence stress-response signalling in keratinocytes. Formulators combine them for structural breadth. The rationale is chemical similarity plus complementary distribution, not a demonstrated additive effect.
Nothing specific on file for Polypodium Leucotomos Extract. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Polypodium Leucotomos Extract actually does.
Polypodium leucotomos extract is a water extract of a Central and South American fern of the Polypodiaceae family, taken from the fronds, the rhizome or both.
Its characterised constituents are hydroxycinnamic and benzoic acid derivatives including ferulic, caffeic, chlorogenic, coumaric, vanillic and 4-hydroxybenzoic acids.
These phenolic acids donate hydrogen atoms to radicals, the chemical basis of their antioxidant behaviour in cell-free and cell-culture systems.
An oral antioxidant reaches skin through the dermal capillary circulation, which distributes it evenly across exposed and covered areas but creates no physical film and blocks no photons.
The forms it comes in.
The essence, in one line each.
- In an eight-week randomised trial, a combination supplement containing red orange and Polypodium leucotomos extract was assessed for how skin responds to sun exposure, so any effect cannot be attributed to Polypodium leucotomos alone.Randomised trial. Keršmanc et al., 2025 (Nutrients). PMID 40218997 ↗
- In a randomised comparison in adults, a fixed Polypodium leucotomos and pomegranate combination was compared with Polypodium leucotomos alone.Randomised trial. Emanuele et al., 2017 (Neuro endocrinology letters). PMID 28456146 ↗
- An oral supplement containing Polypodium leucotomos extract was evaluated for its contribution to sun protection, with light-response measurements as the reported endpoints.Open-label trial. Hussain et al., 2025 (Archives of Dermatological Research). PMID 40095119 ↗
- Narrowband UVB phototherapy combined with the oral extract was reported to produce a greater repigmentation response than phototherapy alone.Randomised trial. Pacifico et al., 2021 (Dermatologic Therapy). PMID 33433041 ↗
- Oral supplementation alongside standard dermatological care of sun-damaged scalp skin was examined for whether it changed the response to that care.Randomised trial. Auriemma et al., 2015 (Dermatologic Surgery). PMID 26218723 ↗
- A single patient taking the oral extract was reported to tolerate light exposure better during phototherapy; a case report describes one person and cannot show cause.Case report. Sharifzadeh et al., 2024 (JAAD Case Reports). PMID 38883171 ↗
- A retrospective series describes tolerability and use patterns of a gummy-format extract in children; retrospective series report what happened rather than what the supplement caused.Case series. Hakim et al., 2026 (Pediatric Dermatology). PMID 42289296 ↗
- A combination of the fern extract with Aspalathus linearis was examined in laboratory models of light-induced cell stress; laboratory findings are mechanistic and do not carry directly to people.In vitro study. Mascaraque et al., 2026 (Pharmaceuticals). PMID 41901339 ↗
- A systematic review of oral supplements in dermatology names the extract among agents with reported photoprotective data and describes the evidence base as limited in size and design.Systematic review. Rodriguez-Luna et al., 2025 (Actas Dermo-Sifiliograficas). PMID 39988198 ↗
- A review of current photoprotection strategies lists oral Polypodium leucotomos extract among the systemic agents studied alongside topical sunscreens, positioning it as an adjunct rather than a replacement for them.Narrative review. Gilaberte et al., 2026 (Cancers). PMID 41749887 ↗
These are the studies our verdict leans on, chosen from the 87 we read for Polypodium Leucotomos Extract. The full linked list is below.
The studies, linked.
3 sources behind our Polypodium Leucotomos Extract verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
- Clinical trialPolypodium Leucotomos Extract as an Adjunct to Sunscreen for the Treatment of MelasmaClinicalTrials.gov ↗NA · 40 participants · Completed
- Clinical trialSingle-Blind Study Determining the Efficacy of Polypodium Leucotomos Extract Supplement in Decreasing UVA Premutagenic and Photoaging MarkersClinicalTrials.gov ↗PHASE2 · 10 participants · Completed
- Clinical trialA Pilot Trial of Polypodium Leucotomos in Preventing Skin Cancer and Its PrecursorsClinicalTrials.gov ↗PHASE1 · Withdrawn
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.